Vanguard Group Inc Elanco Animal Health Inc Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Vanguard Group Inc holds 48,760,977 shares of ELAN stock, worth $549 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
48,760,977
Previous 48,945,483
0.38%
Holding current value
$549 Million
Previous $719 Million
17.82%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding ELAN
# of Institutions
443Shares Held
464MCall Options Held
3.1MPut Options Held
765K-
Dodge & Cox San Francisco, CA83.2MShares$936 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$576 Million0.49% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$262 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$230 Million11.79% of portfolio
-
Dimensional Fund Advisors LP Austin, TX17.9MShares$201 Million0.05% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.33B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...